SEC Form 4 · accession 0001127602-18-008443
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cox
Officer — Chief Executive Officer · Director
Period of report
Feb 22, 2018
Accepted (ET)
Feb 26, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2018 | F | 13,973 | $104.30 | D | 190,888 | D | |
| Common StockF1 | Feb 23, 2018 | F | 5,794 | $104.74 | D | 185,094 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.